Study validates effectiveness of genomic test for lung cancer detection
from Medical Xpress
A new test co-developed by a Boston University School of Medicine researcher will allow patients suspected of having lung cancer to be subjected to fewer and less invasive tests to determine if they have the disease. "We are seeing an increase in the number of lesions suspicious for lung cancer found on chest imaging of current and former smokers. In the past, these patients have been subjected to invasive tests when traditional bronchoscopy tests prove inconclusive. Today's announcement provides physicians and patients with an additional piece of scientifically reliable information to consider when determining their next diagnostic step," said senior author Dr. Avi Spira, MSc, professor of medicine, pathology and bioinformatics at BUSM.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063